Barrier Therapeutics Announces Issuance of Xolegel(TM) Patent (SYS-CON Media)
Posted in Patents on February 20th, 2007Barrier Therapeutics Announces Issuance of Xolegel(TM) Patent (SYS-CON Media)
Barrier Therapeutics, Inc. (NASDAQ: BTRX), apharmaceutical company developing and commercializing products in the fieldof dermatology, today announced the issuance of United States Patent Number7,179,475, entitled ‘Anhydrous Topical Skin Preparations.’ This patentprovides coverage for the specific formulation of ketoconazole in awaterless gel that Barrier Therapeutics markets in the U.S. under …






